ArticleScientific reports2025

Efficacy and safety of trastuzumab deruxtecan in HER2-positive breast cancer patients with brain metastases after failure of pyrotinib-based therapy.

Jinmei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.